Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 157,900 | 138,651 | 147,660 | 123,876 | 153,642 |
| Cost of Goods | 49,118 | 44,422 | 45,570 | 40,820 | 50,986 |
| Gross Profit | 108,782 | 94,229 | 102,090 | 83,056 | 102,656 |
| Operating Expenses | 89,414 | 83,399 | 84,292 | 79,007 | 95,939 |
| Operating Income | 19,486 | 11,252 | 18,368 | 4,869 | 7,703 |
| Interest Expense | 5,306 | 6,177 | 7,494 | 7,509 | 8,997 |
| Other Income | -37 | -405 | -561 | -777 | 1,241 |
| Pre-tax Income | 14,143 | 4,670 | 10,313 | -3,417 | -53 |
| Income Tax | -3,175 | 664 | 1,041 | -95 | 550 |
| Net Income Continuous | 17,318 | 4,006 | 9,272 | -3,322 | -603 |
| Minority Interests | 2,563 | 851 | 1,813 | -685 | -215 |
| Net Income | $14,755 | $3,155 | $7,459 | $-2,637 | $-388 |
| EPS Basic Total Ops | 0.22 | 0.05 | 0.11 | -0.04 | 0.00 |
| EPS Basic Continuous Ops | 0.19 | 0.06 | 0.14 | -0.05 | 0.16 |
| EPS Diluted Total Ops | 0.21 | 0.05 | 0.11 | -0.04 | 0.00 |
| EPS Diluted Continuous Ops | 0.19 | 0.06 | 0.14 | -0.05 | 0.16 |
| EPS Diluted Before Non-Recurring Items | 0.24 | 0.15 | 0.21 | 0.08 | 0.15 |
| EBITDA(a) | $31,180 | $22,655 | $30,417 | $16,734 | $20,108 |